Jeffrey Fryer
Plus aucun poste en cours
Historique de carrière de Jeffrey Fryer
Anciens postes connus de Jeffrey Fryer
Sociétés | Poste | Début | Fin |
---|---|---|---|
RALLYBIO CORPORATION | Directeur Financier/CFO | 01/01/2018 | 01/02/2023 |
Fondateur | 01/01/2018 | 01/02/2023 | |
Treasurer | 01/01/2018 | 01/02/2023 | |
ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2008 | 01/04/2017 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Fondateur | 01/01/2018 | - |
Formation de Jeffrey Fryer
University of Hartford | Graduate Degree |
Bryant University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Founder | 2 |
Director of Finance/CFO | 1 |
Treasurer | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
RALLYBIO CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Jeffrey Fryer
- Expérience